Listar por tema "rituximab"

Ordenar por:Orden:Resultados:

  • Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents 
    Finkelsztejn, A.; Gabbai, A.A.; Fragoso, Y.D.; Carrá, A.; Macías-Islas, M.A.; Arcega-Revilla, R.; García-Bonitto, J.; Oehninger-Gatti, C.L.; Orozco-Escobar, G.; Tarulla, A.; Vergara, F.; Vizcarra-Escobar, Darwin (SP Academia Brasileira de Neurologia, 2012)
    Objective: It is estimated that circa 50,000 individuals have relapsing-remitting multiple sclerosis in Latin America. European and NorthAmerican algorithms for the treatment of multiple sclerosis do not foresee our regional ...
  • Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial 
    Suh, Chang-Hee; Yoo, Dae Hyun; Berrocal Kasay, Alfredo; Chalouhi El-Khouri, Elia; Cons Molina, Francisco Fidenci; Shesternya, Pavel; Miranda, Pedro; Medina-Rodriguez, Francisco G.; Wiland, Piotr; Jeka, Slawomir; Chavez-Corrales, Jose; Linde, Thomas; Hrycaj, Pawel; Abello-Banfi, Mauricio; Hospodarskyy, Ihor; Jaworski, Janusz; Piotrowski, Mariusz; Brzosko, Marek; Krogulec, Marek; Shevchuk, Sergii; Calvo, Armando; Andersone, Daina; Park, Won; Shim, Seung Cheol; Lee, Sang Joon; Lee, Sung Young (Springer, 2019)
    Objective: The aim of this study was to investigate long-term clinical outcomes of extended treatment with CT-P10, a rituximab biosimilar, compared with rituximab reference products sourced from the USA and the EU (US-RTX ...
  • Optimizing outcomes in multiple sclerosis: Consensus guidelines for the diagnosis and treatment of multiple sclerosis in Latin America 
    Carra, A.; Macías Islas, M.A.; Gabbai, A.A.; Correale, J.; Bolana, C.; Sotelo, E.D.; Bonitto, J.G.; Vergara Edwards, F.; Vizcarra-Escobar, Darwin (SAGE Publications, 2011)
    Objective: The prevalence of multiple sclerosis (MS) in Latin America varies across different studies but an intermediate risk and increased frequency of the disease have been reported in recent years. The circumstances ...
  • Systemic lupus erythematosus: A therapeutic challenge for the XXI century 
    Ugarte Gil, Manuel Francisco; Alarcón, Graciela S. (Springer, 2014)
    Despite significant advances in our understanding of the pathogenesis of systemic lupus erythematosus (SLE), there are only a few drugs approved by the regulatory agencies across the world for the treatment of these patients; ...
  • Takayasu Arteritis: Recent Developments 
    Zaldivar Villon, M.L.F.; de la Rocha, J.A.L.; Espinoza, L.R. (Springer, 2019)
    Purpose of Review: Takayasu arteritis (TA) is a granulomatous inflammatory disorder that affects large vessels, especially aorta and its proximal branches. Its diagnosis can be extremely challenging due to the non-specificity ...

Buscar en el Repositorio

Listar

Panel de Control